BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 22497484)

  • 1. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
    Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of ARHI in pT2a and pT2b stage gastric cancer and its clinical significance.
    Wang W; Bu XM; Wang J; Zhang N; Zhao CH
    Oncol Rep; 2012 Jun; 27(6):1953-9. PubMed ID: 22427032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
    Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth.
    He XP; Shao Y; Li XL; Xu W; Chen GS; Sun HH; Xu HC; Xu X; Tang D; Zheng XF; Xue YP; Huang GC; Sun WH
    FEBS J; 2012 Nov; 279(22):4201-12. PubMed ID: 23013439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
    Liu P; Wang TS; You SH; Ge HM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse association between miR-194 expression and tumor invasion in gastric cancer.
    Song Y; Zhao F; Wang Z; Liu Z; Chiang Y; Xu Y; Gao P; Xu H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S509-17. PubMed ID: 21845495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis.
    Huang J; Lin Y; Li L; Qing D; Teng XM; Zhang YL; Hu X; Hu Y; Yang P; Han ZG
    Mol Carcinog; 2009 Feb; 48(2):130-40. PubMed ID: 18612997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of histone deacetylase inhibitors on cell apoptosis and expression of the tumor suppressor genes RUNX3 and ARHI in ovarian tumors.
    Zhang L; Liu P; Li H; Xue F
    Mol Med Rep; 2013 May; 7(5):1705-9. PubMed ID: 23504001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of the hPOT1 gene by RNA inference promotes apoptosis and inhibits proliferation and aggressive phenotype of gastric cancer cells, likely through up-regulating PinX1 expression.
    Wan SM; Tie J; Zhang YF; Guo J; Yang LQ; Wang J; Xia SH; Yang SM; Wang RQ; Fang DC
    J Clin Pathol; 2011 Dec; 64(12):1051-7. PubMed ID: 21778296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of TESTIN in primary gastric cancer].
    Huang W; Weng DS; Pan ZZ; Pan K; Ding PR; Zhou J; Wang H; Zhang HK; Li JJ; Xia JC
    Ai Zheng; 2008 Sep; 27(9):984-8. PubMed ID: 18799041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.
    Nagahara H; Mimori K; Utsunomiya T; Barnard GF; Ohira M; Hirakawa K; Mori M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6800-6. PubMed ID: 16203767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated expression of S100A6 in human gastric cancer.
    Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
    J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.
    Liu Z; Zhu J; Cao H; Ren H; Fang X
    Int J Oncol; 2012 May; 40(5):1553-60. PubMed ID: 22293682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.
    Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ
    Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.